- Phare
- Validé par KD/KO
Anticorps Polyclonal de lapin anti-PAX8
PAX8 Polyclonal Antibody for WB, IHC, IF/ICC, IF-P, IP, ELISA
Hôte / Isotype
Lapin / IgG
Réactivité testée
Humain, souris et plus (5)
Applications
WB, IHC, IF/ICC, IF-P, IP, CoIP, ELISA
Conjugaison
Non conjugué
504
N° de cat : 10336-1-AP
Synonymes
Galerie de données de validation
Applications testées
Résultats positifs en WB | cellules SKOV-3, cellules HEK-293, cellules NIH/3T3, cellules Raji |
Résultats positifs en IP | cellules SKOV-3, cellules HeLa |
Résultats positifs en IHC | tissu de tumeur ovarienne humain, tissu de cancer de la thyroïde humain, tissu de carcinome à cellules rénales humain, tissu rénal de souris il est suggéré de démasquer l'antigène avec un tampon de TE buffer pH 9.0; (*) À défaut, 'le démasquage de l'antigène peut être 'effectué avec un tampon citrate pH 6,0. |
Résultats positifs en IF-P | tissu rénal de souris, |
Résultats positifs en IF/ICC | cellules SKOV-3, |
Dilution recommandée
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:2000-1:10000 |
Immunoprécipitation (IP) | IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate |
Immunohistochimie (IHC) | IHC : 1:1000-1:5000 |
Immunofluorescence (IF)-P | IF-P : 1:50-1:500 |
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, check data in validation data gallery |
Applications publiées
KD/KO | See 5 publications below |
WB | See 55 publications below |
IHC | See 366 publications below |
IF | See 106 publications below |
ELISA | See 1 publications below |
FC | See 1 publications below |
CoIP | See 1 publications below |
Informations sur le produit
10336-1-AP cible PAX8 dans les applications de WB, IHC, IF/ICC, IF-P, IP, CoIP, ELISA et montre une réactivité avec des échantillons Humain, souris
Réactivité | Humain, souris |
Réactivité citée | rat, bovin, Humain, Lapin, poisson-zèbre, porc, souris |
Hôte / Isotype | Lapin / IgG |
Clonalité | Polyclonal |
Type | Anticorps |
Immunogène | Protéine recombinante |
Nom complet | paired box 8 |
Masse moléculaire calculée | 48 kDa |
Poids moléculaire observé | 48 kDa, 58 kDa |
Numéro d’acquisition GenBank | BC001060 |
Symbole du gène | PAX8 |
Identification du gène (NCBI) | 7849 |
Conjugaison | Non conjugué |
Forme | Liquide |
Méthode de purification | Purification par affinité contre l'antigène |
Tampon de stockage | PBS avec azoture de sodium à 0,02 % et glycérol à 50 % pH 7,3 |
Conditions de stockage | Stocker à -20°C. Stable pendant un an après l'expédition. L'aliquotage n'est pas nécessaire pour le stockage à -20oC Les 20ul contiennent 0,1% de BSA. |
Informations générales
PAX8 is a member of the paired box (PAX) family of transcription factors, typically containing a paired box domain and a paired-type homeodomain. It is expressed during organogenesis of the thyroid gland, kidney and Mullerian system. It is thought to regulate the expression of Wilms tumor suppressor (WT1) gene and mutations in PAX8 have been associated with Wilms tumor cells, thyroid and ovarian carcinomas. PAX8 is a useful marker in distinguishing ovarian carcinomas from mammary carcinomas (PMID: 18724243). PAX8 is expressed in a high percentage of ovarian serous, endometrioid, and clear cell carcinomas, but only rarely in primary ovarian mucinous adenocarcinomas.
This antibody can detect all 5 isoforms of PAX8 (31 kDa, 34 kDa, 41 kDa, 43 kDa and 48 kDa). A 58-60 kDa form has also been reported (PMID:15650356, 1049952). Proteintech's 10336-1-AP antibody has cross-reactivities with the other PAX family members.
Protocole
Product Specific Protocols | |
---|---|
WB protocol for PAX8 antibody 10336-1-AP | Download protocol |
IHC protocol for PAX8 antibody 10336-1-AP | Download protocol |
IF protocol for PAX8 antibody 10336-1-AP | Download protocol |
IP protocol for PAX8 antibody 10336-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |
Publications
Species | Application | Title |
---|---|---|
Nature The renal lineage factor PAX8 controls oncogenic signalling in kidney cancer.
| ||
Nat Biotechnol Tubuloids derived from human adult kidney and urine for personalized disease modeling. | ||
Nat Med Combined mutation in Vhl, Trp53 and Rb1 causes clear cell renal cell carcinoma in mice. | ||
Cancer Discov A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear Cell Renal Cell Carcinoma. | ||
Cell Stem Cell Patient-derived organoids model cervical tissue dynamics and viral oncogenesis in cervical cancer. | ||
Cell Stem Cell Generation of Human PSC-Derived Kidney Organoids with Patterned Nephron Segments and a De Novo Vascular Network. |
Avis
The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.
FH Kenzo (Verified Customer) (03-28-2024) | Worked well for immunolabeling on mouse retina tissue sections.
|
FH Eunyoung (Verified Customer) (02-28-2020) | This antibody works well on the mouse ovarian cancer tissue
|
FH shuang (Verified Customer) (02-18-2020) | This Pax8 antibody works great for both IHC and IF staining on mouse Fallopian tube/uterus organoids and tumors, Highly recommend!
|
FH Adam (Verified Customer) (05-30-2019) | Antibody works great for our applications (IHC on FFPE tissues). Only comment is that it cane sometimes have some background staining, particularly in some mouse tissues such as liver.
|
FH Huai-Chin (Verified Customer) (04-15-2019) | So far only try the antibody for IHC on mouse tissue. Works pretty good. Would like to try it on human tissue/cell lines.
|
FH Paulo (Verified Customer) (03-03-2019) | Used to perform ChIP-seq in ccRCC cell lines. 17.5ug of antibody used in 100million cells. IP was validated by WB. Sequencing detected PAX8 binding genome wide. Motif analysis identified the consensus PAX8 binding motif in approximately 90% of detected peaks.Would be great if Proteintech would produce a more concentrated version of this antibody for ChIP-seq.
|